Skip to main
PSX

Phillips 66 (PSX) Stock Forecast & Price Target

Phillips 66 (PSX) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 13%
Buy 44%
Hold 38%
Sell 0%
Strong Sell 6%

Bulls say

Phillips 66 is attractive fundamentally because it combines a large, integrated asset base with diversified earnings streams across Refining, Marketing, Midstream, Chemicals, and Renewables, where Midstream alone contributes about 40% of mid-cycle EBITDA and helps dampen the cyclicality of refining. The company’s refining system is competitive, with roughly 2.0 million barrels per day of capacity, average adjusted EBITDA/bbl of about $7.90 over 2021-25, adjusted controllable costs down by more than $1/bbl since 2022, and a strong ~87% clean product yield in 2024 and 2025, while the Chemicals joint venture benefits from a 40B lbs/yr capacity platform and a rebound in margins in 2026. It is also improving financial flexibility by taking gross debt down toward $17B, reducing leverage from about $21B currently, and still maintaining capital returns through dividends and buybacks while funding acquisitions with divestitures, which supports a constructive outlook on long-term cash generation and shareholder value creation.

Bears say

Phillips 66 is constrained by a balance sheet that still sits above its leverage target as of 1Q quarter end, which has overshadowed a solid operational improvement story over the past ~4 years and helped drive underperformance versus the refining group on a 12- and 24-month basis. Although the company may reach a solid net debt position in the second half and gross debt target by YE27 or shortly after, its capital return capacity appears structurally limited versus large-cap peers, with 2026-27 average total ROC yield estimated at only ~6-7% versus MPC/VLO in the mid-to-high teens. In addition, the breadth of its capital-intensive asset base—10 refineries with 2.0 million barrels per day of throughput capacity, a midstream network spanning 70,000 miles of pipelines and related terminals and processing assets, and CPChem’s chemical operations in the United States and the Middle East—supports long-term scale but also reinforces the funding demands that can keep shareholder returns constrained.

Phillips 66 (PSX) has been analyzed by 16 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 44% recommend Buy, 38% suggest Holding, 0% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phillips 66 and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phillips 66 (PSX) Forecast

Analysts have given Phillips 66 (PSX) a Buy based on their latest research and market trends.

According to 16 analysts, Phillips 66 (PSX) has a Buy consensus rating as of Oct 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $241.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $241.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phillips 66 (PSX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.